x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Wegovy

Inception Point Ai

This series on Wegovy provides an in-depth look into the popular weight loss medication. The first episode introduces Wegovy, explaining its mechanism, clinical trials, and patient eligibility. The second episode delves into the benefits and potential risks, including effectiveness, side effects, and comparisons with other treatments. The final episode covers practical considerations such as usage, lifestyle integration, cost, and future developments. This series offers a comprehensive understanding

health & fitness medicine

All Episodes

6:31

Medicare Approves Wegovy Coverage in 2026 as Oral...

Wegovy ·

2026/04/25

# SEO-Friendly Podcast Episode Description## Wegovy Revolution: Medicare Coverage, Oral Pills & Weight Loss Breakthroughs in 2026Join host Alexandra Reeves for an in-depth exploration of the seismic shifts transforming obesity treatment in America. This episode covers groundbreaking developments in GLP-1 medications, featuring exclusive insights on Wegovy's historic Medicare coverage expansion, the explosive launch of the first FDA-approved oral weight loss pill, and revolutionary high-dose

en

6:01

Wegovy Pill Surges With 600000 Prescriptions in Two...

Wegovy ·

2026/04/21

# SEO-Friendly Podcast Episode Description## Wegovy Pill Revolution: 600,000 Prescriptions in 60 Days | The Weight Loss Game-Changer of 2026Join investigative journalist Alexandra Reeves as she unpacks the explosive launch of **Wegovy pill (oral semaglutide)**, the FDA-approved weight loss medication that's transforming obesity treatment in 2026.### What You'll Discover:**Breaking Market Data:**- Over 600,000 Wegovy pill prescriptions filled in just two months (Jan-Feb 2026)- Projected $15.9 billion

en

7:05

Wegovy Oral Pill Launch: FDA Approval, Clinical...

Wegovy ·

2026/04/18

# Wegovy Revolution: Oral Pill Launch, Higher Doses, and Legal Battles Explained | April 2025 UpdateJoin veteran health journalist Alexandra Reeves for an in-depth exploration of Wegovy's groundbreaking developments in April 2025. This episode covers Novo Nordisk's game-changing oral semaglutide pill that generated 600,000+ prescriptions in just two months, the new high-dose Wegovy HD (7.2mg) injectable, and competitive threats from Eli Lilly's Foundayo.**What You'll Learn:**- Oral Wegovy results:

en

6:14

Wegovy and GLP-1 Drugs Transform Weight Loss...

Wegovy ·

2026/04/14

# SEO-Friendly Podcast Episode Description## Wegovy Breakthrough: New High-Dose Pen, Oral Pills & GLP-1 Weight Loss Updates 2026Discover the latest **Wegovy and GLP-1 weight loss** innovations in this comprehensive episode. Host Alexandra Reeves breaks down groundbreaking developments reshaping obesity treatment worldwide.**What You'll Learn:**🔬 **EMA Approval News** - Wegovy injection's revolutionary 48-hour controlled-temperature delivery at 30°C, eliminating cold-chain logistics headaches across

en

6:22

Wegovy HD and European Storage Approval Expand Access...

Wegovy ·

2026/04/11

# Wegovy Breakthrough: EU Approval for Flexible Delivery & New High-Dose Launch in the USJoin veteran journalist Alexandra Reeves as she unpacks the latest game-changing developments in weight management medicine. In this episode, discover how **Novo Nordisk's Wegovy is revolutionizing obesity treatment** with two major announcements from April 2026.## What You'll Learn:**European Delivery Breakthrough**: The European Medicines Agency's April 9, 2026 approval allowing Wegovy to be delivered at

en

6:14

Wegovy HD Now Available Nationwide: New 7.2mg Dose...

Wegovy ·

2026/04/07

# SEO-Friendly Podcast Episode Description## Wegovy HD Launch & The Battle of Obesity Medications: What You Need to KnowJoin veteran journalist Alexandra Reeves as she breaks down the latest developments in weight loss medicine, focusing on **Novo Nordisk's groundbreaking Wegovy HD launch** and the intensifying competition in the obesity treatment market.### Episode Highlights:**Wegovy HD Nationwide Rollout** - Learn about the new 7.2mg high-dose semaglutide now available at 70,000+ U.S. pharmacies,

en

5:58

Wegovy Dominates GLP-1 Market With New HD Dose, Oral...

Wegovy ·

2026/04/04

# Wegovy Breakthrough: New High-Dose Approval, NHS Expansion & Pill Wars with Eli Lilly | Obesity Treatment Update 2026Join veteran health journalist Alexandra Reeves as she unpacks the explosive developments in obesity treatment centered on Novo Nordisk's Wegovy (semaglutide). In this comprehensive episode, discover:**Major Wegovy Developments Covered:**- **ORION Study Results**: New data shows Wegovy's 25mg pill outperforms Eli Lilly's orforglipron (Foundayo) by 3.2 percentage points in weight

en

5:54

Wegovy Multi-Month Subscription Launches Today Saving...

Wegovy ·

2026/03/31

# Wegovy Revolution: Multi-Month Subscriptions, New High-Dose Approval & The Weight Loss Drug Wars of 2026Join veteran journalist Alexandra Reeves for an in-depth exploration of the seismic shifts transforming the weight loss medication landscape. In this compelling episode, discover how Novo Nordisk's groundbreaking Wegovy subscription program is making obesity treatment more accessible and affordable than ever before.**What You'll Learn:**🔹 **Breaking News:** Novo Nordisk's world-first

en

6:48

FDA Approves Wegovy HD Triple Dose for Weight Loss,...

Wegovy ·

2026/03/28

# SEO-Friendly Podcast Episode Description## Wegovy HD Approved: Revolutionary 7.2mg Dose Delivers 21% Weight Loss | FDA Fast-Track Approval ExplainedJoin veteran journalist Alexandra Reeves from Copenhagen as she breaks down the groundbreaking FDA approval of **Wegovy HD** (semaglutide 7.2mg) – the highest-dose GLP-1 weight loss medication now available in the US and Europe.**What You'll Learn:**- **FDA's Record-Breaking Approval**: How Wegovy HD received approval in just 54 days under the National

en

5:26

FDA Approves Wegovy HD Higher Dose Injection for...

Wegovy ·

2026/03/24

# Wegovy HD Approval: New Higher-Dose Weight Loss Drug, Global Competition & What You Need to KnowJoin investigative health journalist Alexandra Reeves as she breaks down the groundbreaking FDA approval of Wegovy HD (7.2mg semaglutide) for weight loss and its global implications. This comprehensive podcast episode covers:**Key Topics:**- FDA's fast-track approval of Wegovy HD on March 19, 2026 (54-day record timeline)- STEP UP clinical trial results showing 21% average weight loss vs. 16% with

en

7:12

FDA Approves Wegovy HD 7.2mg for Obesity, Delivering...

Wegovy ·

2026/03/21

# SEO-Friendly Podcast Episode Description## Wegovy HD Approved: FDA Fast-Tracks Higher-Dose Weight Loss Drug with 20% ResultsDiscover the groundbreaking FDA approval of Wegovy HD (7.2mg semaglutide) - Novo Nordisk's higher-dose obesity treatment delivering unprecedented 20.7% average weight loss in clinical trials. Host Alexandra Reeves breaks down the March 2026 approval that came through the FDA's accelerated National Priority Voucher program in just 54 days.**In This Episode:**- **Clinical trial

en

7:02

Wegovy Pill Approval Transforms Weight Loss Market...

Wegovy ·

2026/03/17

# SEO-Friendly Podcast Episode Description## Wegovy's Pill Revolution: Reshaping the Weight Loss LandscapeDiscover how Novo Nordisk's groundbreaking FDA-approved oral Wegovy pill is transforming obesity treatment and the $100+ billion weight loss drug market. Hosted by veteran pharmaceutical analyst Alexandra Reeves.**In This Episode:**🔬 **Breaking News Analysis** - Learn about the December 2025 FDA approval that created the first oral GLP-1 pill for chronic weight management, generating over

en

6:11

Wegovy Pill Approved FDA 2026 Weight Loss...

Wegovy ·

2026/03/14

# Wegovy Pill Revolution: FDA Approval, Weight Loss Results & Vision Risks Explained | 2026 Update**Episode Description:**Join investigative journalist Alexandra Reeves from Copenhagen as she unpacks the groundbreaking transition of Wegovy from injection to pill form in this essential March 2026 health update. **What You'll Learn:**🔹 **FDA-Approved Wegovy Pill Launch** - December 2025 approval details, nationwide availability at $149/month through savings programs, and why this needle-free option

en

6:56

Novo Nordisk and Hims Settle Wegovy Patent Dispute,...

Wegovy ·

2026/03/10

# SEO-Friendly Podcast Episode Description## Wegovy Breakthrough: Novo Nordisk & Hims Strike Landmark Deal in Weight Loss Drug BattleJoin veteran journalist Alexandra Reeves from Copenhagen as she unpacks the groundbreaking settlement between pharmaceutical giant Novo Nordisk and telehealth disruptor Hims & Hers that's reshaping access to weight loss medications.**In This Episode:**🔬 **Major Settlement Details** - How Novo Nordisk and Hims ended their patent dispute over Wegovy (semaglutide), and

en

6:32

Wegovy Price Cuts, Patent Cliffs, and Global Health...

Wegovy ·

2026/03/07

# Wegovy Revolution: Sweden's Refusal, Price Cuts & the New Pill Form | Medical & Economic AnalysisJoin Alexandra Reeves for an in-depth exploration of the latest Wegovy developments reshaping obesity treatment worldwide. This episode examines Sweden's controversial decision to deny government subsidies for Wegovy despite its proven effectiveness, citing potential costs that could overwhelm their entire national drug budget.Discover why Novo Nordisk is slashing U.S. prices to $675/month by 2027,

en

7:18

Wegovy Pill Approved FDA 2025 Weight Loss Semaglutide...

Wegovy ·

2026/03/03

# Wegovy Revolution: Oral Pills, Higher Doses & Global Expansion - A Comprehensive Update on Semaglutide for Weight LossJoin Alexandra Reeves for an in-depth exploration of the groundbreaking developments in obesity treatment with Wegovy (semaglutide). This episode covers the FDA-approved oral pill version that launched in January 2025, eliminating needles and offering convenient daily dosing with impressive 14% weight loss results from clinical trials.Discover the latest on Europe's newly approved

en

6:17

Novo Nordisk Cuts Wegovy and Ozempic Prices by 50...

Wegovy ·

2026/02/28

# Wegovy and Ozempic Price Cuts: What the 50% Reduction Means for Patients | Healthcare AnalysisJoin veteran journalist Alexandra Reeves for an in-depth analysis of Novo Nordisk's groundbreaking announcement to cut Wegovy and Ozempic prices by 50% starting January 2027. In this comprehensive episode, discover what's driving the dramatic price reduction, who will actually benefit, and what it means for the competitive GLP-1 medication landscape.**Key Topics Covered:**• **Wegovy and Ozempic price cuts

en

6:49

Novo Nordisk Slashes Wegovy Price to 675 Monthly...

Wegovy ·

2026/02/24

# Wegovy Price Cuts and Oral Pill Revolution: Major Updates in Obesity Treatment | SEO Description**Podcast Episode Description:**Discover the groundbreaking changes reshaping obesity treatment in America. In this episode, veteran journalist Alexandra Reeves breaks down Novo Nordisk's dramatic announcement: a significant Wegovy price reduction to $675/month starting January 2027, making the popular weight loss medication more accessible to over 100 million Americans with obesity.Learn about the

en

6:50

Wegovy Semaglutide Sparks Global Healthcare Debate:...

Wegovy ·

2026/02/17

# Wegovy's Global Revolution: High-Dose EU Approval and Pharmaceutical Legal BattlesExplore the latest developments in the semaglutide revolution as Alexandra Reeves breaks down Wegovy's European Commission win with a new 7.2mg high-dose approval. This episode unpacks how patients across the EU can now access enhanced treatment options showing up to 21% body weight reduction in clinical trials. Dive into the pharmaceutical drama unfolding in the US, where telehealth company Hims & Hers faces legal

en

6:58

Wegovy Oral Pill Sparks Controversy: FDA Warns of...

Wegovy ·

2026/02/14

# Wegovy's Evolution: From Innovative Delivery Systems to Regulatory Battles in the Weight Loss MarketDive into the latest developments surrounding Novo Nordisk's groundbreaking weight loss medication Wegovy in this comprehensive episode of Global Health Watch. Host Alexandra Reeves explores how this GLP-1 receptor agonist is transforming the obesity treatment landscape through innovative delivery methods, including new vial formats and the recently FDA-approved oral semaglutide pill.Discover the

en

105 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown